These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29172690)

  • 1. Role of MeCP2 in neurological disorders: current status and future perspectives.
    Ausió J
    Epigenomics; 2018 Jan; 10(1):5-8. PubMed ID: 29172690
    [No Abstract]   [Full Text] [Related]  

  • 2. Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders.
    Meng X; Wang W; Lu H; He LJ; Chen W; Chao ES; Fiorotto ML; Tang B; Herrera JA; Seymour ML; Neul JL; Pereira FA; Tang J; Xue M; Zoghbi HY
    Elife; 2016 Jun; 5():. PubMed ID: 27328325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methyl-CpG-binding protein MeCP2 and neurological disease.
    Bird A
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):575-83. PubMed ID: 18631120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2 post-translational regulation through PEST domains: two novel hypotheses: potential relevance and implications for Rett syndrome.
    Thambirajah AA; Eubanks JH; Ausió J
    Bioessays; 2009 May; 31(5):561-9. PubMed ID: 19319913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel function of MeCP2 in the pathophysiology of Rett syndrome: Regulation of mTOR signaling mediated by MeCP2-dependent microRNA processing].
    Tsujimura K; Nakashima K
    Seikagaku; 2017 Feb; 89(1):51-61. PubMed ID: 29624958
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of epigenetics in Rett syndrome.
    Kubota T; Miyake K; Hirasawa T
    Epigenomics; 2013; 5(5):583-92. PubMed ID: 24059803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeCP2 in central nervous system glial cells: current updates.
    Sharma K; Singh J; Frost EE; Pillai PP
    Acta Neurobiol Exp (Wars); 2018; 78(1):30-40. PubMed ID: 29694339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rett syndrome: prevalence among Chinese and a comparison of MECP2 mutations of classic Rett syndrome with other neurodevelopmental disorders.
    Wong VC; Li SY
    J Child Neurol; 2007 Dec; 22(12):1397-400. PubMed ID: 18174559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MeCP2: the long trip from a chromatin protein to neurological disorders.
    Ausió J; Martínez de Paz A; Esteller M
    Trends Mol Med; 2014 Sep; 20(9):487-98. PubMed ID: 24766768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeCP2 and the enigmatic organization of brain chromatin. Implications for depression and cocaine addiction.
    Ausió J
    Clin Epigenetics; 2016; 8():58. PubMed ID: 27213019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MeCP2 phosphorylation in the brain: from transcription to behavior.
    Damen D; Heumann R
    Biol Chem; 2013 Dec; 394(12):1595-605. PubMed ID: 23912219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2_E1 N-terminal modifications affect its degradation rate and are disrupted by the Ala2Val Rett mutation.
    Sheikh TI; de Paz AM; Akhtar S; Ausió J; Vincent JB
    Hum Mol Genet; 2017 Nov; 26(21):4132-4141. PubMed ID: 28973632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mRNA splicing by MeCP2 via epigenetic modifications in the brain.
    Cheng TL; Chen J; Wan H; Tang B; Tian W; Liao L; Qiu Z
    Sci Rep; 2017 Feb; 7():42790. PubMed ID: 28211484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advances of DNA methylation and histone modifications in rheumatoid arthritis, with special emphasis on MeCP2.
    Miao CG; Yang YY; He X; Li J
    Cell Signal; 2013 Apr; 25(4):875-82. PubMed ID: 23277203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Regulation of MeCP2 Phosphorylation by Laminin in Oligodendrocytes.
    Parikh ZS; Tripathi A; Pillai PP
    J Mol Neurosci; 2017 Aug; 62(3-4):309-317. PubMed ID: 28616777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
    Tao J; Wu H; Sun YE
    Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rett syndrome: disruption of epigenetic control of postnatal neurological functions.
    Pohodich AE; Zoghbi HY
    Hum Mol Genet; 2015 Oct; 24(R1):R10-6. PubMed ID: 26060191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MECP2 mutations are an infrequent cause of mental retardation associated with neurological problems in male patients.
    Moog U; Van Roozendaal K; Smeets E; Tserpelis D; Devriendt K; Buggenhout GV; Frijns JP; Schrander-Stumpel C
    Brain Dev; 2006 Jun; 28(5):305-10. PubMed ID: 16376510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.